Cargando…
Can Voluntary Health Insurance for Non-reimbursed Expensive New Treatments Be Just?
Public healthcare systems are increasingly refusing (temporarily) to reimburse newly approved medical treatments of insufficient or uncertain cost-effectiveness. As both patient demand for these treatments and their list prices increase, a market might arise for voluntary additional health insurance...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401491/ https://www.ncbi.nlm.nih.gov/pubmed/37547913 http://dx.doi.org/10.1093/phe/phad015 |